Healthcare provider profile · identity verified

Matthew A Shehan, M.D.

Internal Medicine · OMAHA, NE · NPI 1972526622

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	763	202
Levothyroxine Sodium	Levothyroxine Sodium	442	103
Amlodipine Besylate	Amlodipine Besylate	436	111
Losartan Potassium	Losartan Potassium	403	108
Omeprazole	Omeprazole	371	93
Metoprolol Succinate	Metoprolol Succinate	364	96
Rosuvastatin Calcium	Rosuvastatin Calcium	340	91
Duloxetine Hcl	Duloxetine Hcl	311	82
Pravastatin Sodium	Pravastatin Sodium	271	74
Alendronate Sodium	Alendronate Sodium	234	75
Gabapentin	Gabapentin	207	65
Eliquis	Apixaban	199	36
Potassium Chloride	Potassium Chloride	172	46
Lovastatin	Lovastatin	155	43
Pantoprazole Sodium	Pantoprazole Sodium	155	42
Furosemide	Furosemide	154	42
Tamsulosin Hcl	Tamsulosin Hcl	150	47
Carvedilol	Carvedilol	147	42
Lisinopril	Lisinopril	135	36
Escitalopram Oxalate	Escitalopram Oxalate	129	29
Warfarin Sodium	Warfarin Sodium	120	22
Allopurinol	Allopurinol	112	26
Trazodone Hcl	Trazodone Hcl	98	21
Ezetimibe	Ezetimibe	97	29
Famotidine	Famotidine	95	29
Metformin Hcl	Metformin Hcl	86	23
Spironolactone	Spironolactone	86	24
Sertraline Hcl	Sertraline Hcl	82	19
Albuterol Sulfate Hfa	Albuterol Sulfate	81	29
Fluticasone Propionate	Fluticasone Propionate	81	34
Hydrochlorothiazide	Hydrochlorothiazide	80	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	79	18
Clopidogrel	Clopidogrel Bisulfate	78	21
Simvastatin	Simvastatin	75	22
Tizanidine Hcl	Tizanidine Hcl	74	22
Meloxicam	Meloxicam	72	24
Finasteride	Finasteride	69	16
Venlafaxine Hcl Er	Venlafaxine Hcl	66	14
Mirtazapine	Mirtazapine	62	15
Prednisone	Prednisone	59	17
Farxiga	Dapagliflozin Propanediol	54	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	12
Bupropion Xl	Bupropion Hcl	51	suppressed
Mounjaro	Tirzepatide	49	suppressed
Celecoxib	Celecoxib	47	16
Chlorthalidone	Chlorthalidone	46	14
Metoprolol Tartrate	Metoprolol Tartrate	46	11
Donepezil Hcl	Donepezil Hcl	45	suppressed
Montelukast Sodium	Montelukast Sodium	43	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Metformin Hcl Er	Metformin Hcl	42	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	41	28
Benazepril Hcl	Benazepril Hcl	40	suppressed
Pregabalin	Pregabalin	38	suppressed
Testosterone Cypionate	Testosterone Cypionate	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	26
Jardiance	Empagliflozin	36	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	11
Doxycycline Hyclate	Doxycycline Hyclate	33	25
Synthroid	Levothyroxine Sodium	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Nitroglycerin	Nitroglycerin	32	12
Ramipril	Ramipril	31	suppressed
Torsemide	Torsemide	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	26	suppressed
Glipizide	Glipizide	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Ondansetron Hcl	Ondansetron Hcl	24	12
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Lorazepam	Lorazepam	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	19	11
Lansoprazole	Lansoprazole	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cephalexin	Cephalexin	17	12
Colestipol Hcl	Colestipol Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Topiramate	Topiramate	17	suppressed
Invokana	Canagliflozin	16	suppressed
Desipramine Hcl	Desipramine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Famciclovir	Famciclovir	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Cefdinir	Cefdinir	13	13
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error